CoChat

Cardiopatch platform enables maturation and scale-up of human pluripotent stem cell-derived engineered heart tissues

Open access

The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.

Abstract

Despite increased use of human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) for drug development and disease modeling studies, methods to generate large, functional heart tissues for human therapy are lacking. Here we present a “Cardiopatch” platform for 3D culture and maturation of hiPSC-CMs that after 5 weeks of differentiation show robust electromechanical coupling, consistent H-zones, I-bands, and evidence for T-tubules and M-bands. Cardiopatch maturation markers and functional output increase during culture, approaching values of adult myocardium. Cardiopatches can be scaled up to clinically relevant dimensions, while preserving spatially uniform properties with high conduction velocities and contractile stresses. Within window chambers in nude mice, cardiopatches undergo vascularization by host vessels and continue to fire Ca 2+ transients. When implanted onto rat hearts, cardiopatches robustly engraft, maintain pre-implantation electrical function, and do not increase the incidence of arrhythmias. These studies provide enabling technology for future use of hiPSC-CM tissues in human heart repair.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-017-01946-x

Cites

69 of 69 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Structural characterization and maturation of hiPSC-CM cardiopatches. a Representative flow cytometry histogram from hiPSC-CMs after 20 days of differentiation. b Photo of a 7 × 7 mm hiPSC-CM-derived tissue patch (human “cardiopatch”) surrounded by a Cerex® frame. c Representative cross-sectional confocal image of 3-week-old cardiopatch demonstrating several layers of densely packed sarcomeric α-actinin (SAA)+ hiPSC-CMs (C1) surrounded by a layer of vimentin (Vim)+ fibroblasts (C2). d, e Representative confocal images of connexin-43 (Cx43, d) and N-Cadherin (NCad, e) junctions in cardiopatch. f, g Representative confocal images (f) and quantification (g) of Ki67+/Nkx2.5+ CMs after 1, 2, and 3 weeks of cardiopatch culture; n = 8/11/12 patches (for 1/2/3 week) from four differentiations; *p = 0.037, **p = 0.0033, ***p < 0.0001, post-hoc Tukey’s test. h, i Relative fractions of myosin light chain 2v (ventricular) and 2a + 2v (atrial/early ventricular) positive hiPSC-CMs within cardiopatches cultured for 1–3 weeks; n = 7/5/4 patches (for 1/2/3 week) from four differentiations; *p = 0.0002 vs. 1 week, post-hoc Tukey’s test. Data are presented as mean ± SEM. Scale bars b 5 mm; c 25 µm (C1–C2, 50 µm); d, e 10 µm; f–h 50 µm
Fig. 1 Structural characterization and maturation of hiPSC-CM cardiopatches. a Representative flow cytometry histogram from hiPSC-CMs after 20 days of differentiation. b Photo of a 7 × 7 mm hiPSC-CM-derived tissue patch (human “cardiopatch”) surrounded by a Cerex® frame. c Representative cross-sectional confocal image of 3-week-old cardiopatch demonstrating several layers of densely packed sarcomeric α-actinin (SAA)+ hiPSC-CMs (C1) surrounded by a layer of vimentin (Vim)+ fibroblasts (C2). d, e Representative confocal images of connexin-43 (Cx43, d) and N-Cadherin (NCad, e) junctions in cardiopatch. f, g Representative confocal images (f) and quantification (g) of Ki67+/Nkx2.5+ CMs after 1, 2, and 3 weeks of cardiopatch culture; n = 8/11/12 patches (for 1/2/3 week) from four differentiations; *p = 0.037, **p = 0.0033, ***p < 0.0001, post-hoc Tukey’s test. h, i Relative fractions of myosin light chain 2v (ventricular) and 2a + 2v (atrial/early ventricular) positive hiPSC-CMs within cardiopatches cultured for 1–3 weeks; n = 7/5/4 patches (for 1/2/3 week) from four differentiations; *p = 0.0002 vs. 1 week, post-hoc Tukey’s test. Data are presented as mean ± SEM. Scale bars b 5 mm; c 25 µm (C1–C2, 50 µm); d, e 10 µm; f–h 50 µmCC BY · PubMed Central
Fig. 2 Functional assessment and maturation of human cardiopatches. a Representative isometric contractile (active) force traces of spontaneously beating hiPSC-CM cardiopatches at 1, 2, and 3 weeks of culture. b Maximum active force (left) and specific force (right) of 1, 2, and 3-week-old cardiopatches; n = 6 patches from two differentiations; *p < 0.0001, post hoc Tukey’s test. c Active and passive force–length relationships of isometrically tested (1 Hz stimulation) cardiopatches at 1, 2, and 3 weeks of culture; same patches as in b. d, e Representative isochrone activation maps (d) and average conduction velocities (CV, e) during point stimulation from bottom right corner (pulse sign) of cardiopatches at 1, 2, and 3 weeks of culture; n = 7/7/9 patches (for 1/2/3 weeks) from two differentiations; *p < 0.0001, post hoc Tukey’s test. Scale bars d, 2 mm. f Average active force, specific force, and CV in cardiopatches obtained from three additional hESC lines (Hes2, H9, and RUES2) normalized to those made of hiPSC-CMs; n = 18/37/22 patches (for Hes2/H9/RUES2) from five to seven independent differentiations per line. g, h Maximum active force (g) and specific force (h) of cardiopatches cultured for 3 weeks in 3D RB + medium or 1, 2, and 3 weeks in 5% FBS medium; n = 15/14/13/14 patches (for 3D RB+/1/2/3 weeks in 5% FBS) from five differentiations; *p = 0.0026, **p = 0.0005, ***p < 0.0001, # p < 0.001 vs. all other groups, post hoc Tukey’s test. i, j CV (i) and action potential duration at 80% repolarization (APD80, j) in cardiopatches cultured for 3 weeks in 3D RB + medium or 1, 2, and 3 weeks in 5% FBS medium; n = 15/15/14/15 patches (for 3D RB+/1/2/3 weeks in 5% FBS) from five differentiations; ***p < 0.0001, # p < 0.002 vs. all other groups, post hoc Tukey’s test. Data are presented as mean ± SEM
Fig. 2 Functional assessment and maturation of human cardiopatches. a Representative isometric contractile (active) force traces of spontaneously beating hiPSC-CM cardiopatches at 1, 2, and 3 weeks of culture. b Maximum active force (left) and specific force (right) of 1, 2, and 3-week-old cardiopatches; n = 6 patches from two differentiations; *p < 0.0001, post hoc Tukey’s test. c Active and passive force–length relationships of isometrically tested (1 Hz stimulation) cardiopatches at 1, 2, and 3 weeks of culture; same patches as in b. d, e Representative isochrone activation maps (d) and average conduction velocities (CV, e) during point stimulation from bottom right corner (pulse sign) of cardiopatches at 1, 2, and 3 weeks of culture; n = 7/7/9 patches (for 1/2/3 weeks) from two differentiations; *p < 0.0001, post hoc Tukey’s test. Scale bars d, 2 mm. f Average active force, specific force, and CV in cardiopatches obtained from three additional hESC lines (Hes2, H9, and RUES2) normalized to those made of hiPSC-CMs; n = 18/37/22 patches (for Hes2/H9/RUES2) from five to seven independent differentiations per line. g, h Maximum active force (g) and specific force (h) of cardiopatches cultured for 3 weeks in 3D RB + medium or 1, 2, and 3 weeks in 5% FBS medium; n = 15/14/13/14 patches (for 3D RB+/1/2/3 weeks in 5% FBS) from five differentiations; *p = 0.0026, **p = 0.0005, ***p < 0.0001, # p < 0.001 vs. all other groups, post hoc Tukey’s test. i, j CV (i) and action potential duration at 80% repolarization (APD80, j) in cardiopatches cultured for 3 weeks in 3D RB + medium or 1, 2, and 3 weeks in 5% FBS medium; n = 15/15/14/15 patches (for 3D RB+/1/2/3 weeks in 5% FBS) from five differentiations; ***p < 0.0001, # p < 0.002 vs. all other groups, post hoc Tukey’s test. Data are presented as mean ± SEMCC BY · PubMed Central
Fig. 3 Lowering density of hiPSC-CMs improves cardiopatch function. a Representative confocal images of 3-week-old cardiopatches generated from 1 million (1MM) and 0.5 million (0.5MM) hiPSC-CMs stained for SAA. Scale bar 50 µm. b Quantification of average number of cells per field of view in 0.5 and 1MM cardiopatches using a ×63 objective (2 µm slice); n = 13/16 patches (1/0.5MM) from seven differentiations, three to four random fields of view per patch; *p = 0.0083, unpaired t-test. c Representative optical cross-sections of 1MM and 0.5MM cardiopatches. Scale bar 10 µm. d Quantification of cardiopatch thickness made from 0.5 and 1MM cells; n = 22/25 patches (1/0.5MM) from 7/11 differentiations, average 2 thickness measurements per patch; *p < 0.0001, unpaired t-test. e Calculated cell numbers in cardiopatches (normalized to 1MM patch) based on average patch thickness and cells per field of view; n = 13/16 patches (1/0.5MM) from seven differentiations; *p < 0.001, unpaired t-test. f Representative confocal images of 3 week 0.5MM cardiopatches stained for Cx43, SAA and NCad. Scale bar 10 µm. g Maximum active force, specific force, and force per input hiPSC-CM in 1MM and 0.5MM cardiopatches; n = 36/35 patches (1/0.5MM) from 13 differentiations; *p = 0.047, **p = 0.0021, ***p < 0.0001, unpaired t-test. h Conduction velocity (CV) and action potential duration at 80% repolarization (APD80) of 1MM and 0.5MM cardiopatches; n = 42/44 patches (1/0.5MM) from 10 differentiations; **p = 0.0028, unpaired t-test. Data in b, d, and e presented as mean ± SEM, while dot plots in g and h show all data points along with mean value (black line)
Fig. 3 Lowering density of hiPSC-CMs improves cardiopatch function. a Representative confocal images of 3-week-old cardiopatches generated from 1 million (1MM) and 0.5 million (0.5MM) hiPSC-CMs stained for SAA. Scale bar 50 µm. b Quantification of average number of cells per field of view in 0.5 and 1MM cardiopatches using a ×63 objective (2 µm slice); n = 13/16 patches (1/0.5MM) from seven differentiations, three to four random fields of view per patch; *p = 0.0083, unpaired t-test. c Representative optical cross-sections of 1MM and 0.5MM cardiopatches. Scale bar 10 µm. d Quantification of cardiopatch thickness made from 0.5 and 1MM cells; n = 22/25 patches (1/0.5MM) from 7/11 differentiations, average 2 thickness measurements per patch; *p < 0.0001, unpaired t-test. e Calculated cell numbers in cardiopatches (normalized to 1MM patch) based on average patch thickness and cells per field of view; n = 13/16 patches (1/0.5MM) from seven differentiations; *p < 0.001, unpaired t-test. f Representative confocal images of 3 week 0.5MM cardiopatches stained for Cx43, SAA and NCad. Scale bar 10 µm. g Maximum active force, specific force, and force per input hiPSC-CM in 1MM and 0.5MM cardiopatches; n = 36/35 patches (1/0.5MM) from 13 differentiations; *p = 0.047, **p = 0.0021, ***p < 0.0001, unpaired t-test. h Conduction velocity (CV) and action potential duration at 80% repolarization (APD80) of 1MM and 0.5MM cardiopatches; n = 42/44 patches (1/0.5MM) from 10 differentiations; **p = 0.0028, unpaired t-test. Data in b, d, and e presented as mean ± SEM, while dot plots in g and h show all data points along with mean value (black line)CC BY · PubMed Central
Fig. 4 Increased cell maturation and size in low-density cardiopatches. a Relative expression levels of 10 maturation genes in d0, 1 week, 2 week, and 3 week cardiopatches compared with those in adult human left ventricles (LV). Linear regression from d0 to 3 weeks: TNNI3, MYL2, MYOM2, CASQ2, p < 0.0001; MYOM3, CKMT2, p < 0.014; S100A1, COX6A2, CKM, p < 0.006; PLN, p = 0.1081. *p < 0.05, **p < 0.001, ***p < 0.0001 vs. d0; # p < 0.023, ## p < 0.0006, ### p < 0.0001 vs. 1 week; † p < 0.037, †† p < 0.0037 vs. 2 week, via post hoc Tukey’s tests. For clarity, only 3-week statistical comparisons are shown. b Relative gene expression in 0.5MM vs. 1MM cardiopatches; *p < 0.041, **p < 0.0073, ***p < 0.0001, post hoc Tukey’s tests. c Protein/DNA ratio in 0.5MM vs. 1MM cardiopatches; n = 3/4 patches (1/0.5MM). d Representative western blots for myosin heavy chain-β (βMHC), SAA, lamin B1 (LamB1), GAPDH, and Cx43 in d0 cells and 3-week 0.5MM and 1MM cardiopatches; dotted line indicates lanes spliced from the same gel. e Quantified protein levels in d0 cells, 1MM and 0.5MM cardiopatches normalized to nuclear envelope protein LamB1, shown relative to 1MM cardiopatches; **p < 0.01, ***p < 0.001 vs. d0; † p < 0.05, †† p < 0.01, ††† p < 0.001 vs. 1MM, post hoc Tukey’s tests. For gene expression studies (a, b), n = 6 patches from two differentiations; for protein studies (c–e), n = 8/10 patches (1/0.5MM) from three to four differentiations. f Representative low-magnification view of cell nucleus (nuc) and surrounding sacromeric structures (sarc) in 3-week-old 0.5MM cardiopatches. Scale bar 2 µm. g Localization of I-bands, Z-discs, and H-zones within hiPSC-CM sarcomeres. Scale bar 1 µm. h Average number of H-zones and I-bands per sarcomere; n = 4 patches from two differentiations, data compiled from a total of 74 random fields of view. i Mitochondria (mito) were found positioned alongside CM myofibrils. Scale bar 500 nm. j, k Evidence of M-bands (j) and T-tubular-like structures (T-t, k) in 3-week-old 0.5MM cardiopatches. Scale bars 500 nm. All data are presented as mean ± SEM
Fig. 4 Increased cell maturation and size in low-density cardiopatches. a Relative expression levels of 10 maturation genes in d0, 1 week, 2 week, and 3 week cardiopatches compared with those in adult human left ventricles (LV). Linear regression from d0 to 3 weeks: TNNI3, MYL2, MYOM2, CASQ2, p < 0.0001; MYOM3, CKMT2, p < 0.014; S100A1, COX6A2, CKM, p < 0.006; PLN, p = 0.1081. *p < 0.05, **p < 0.001, ***p < 0.0001 vs. d0; # p < 0.023, ## p < 0.0006, ### p < 0.0001 vs. 1 week; † p < 0.037, †† p < 0.0037 vs. 2 week, via post hoc Tukey’s tests. For clarity, only 3-week statistical comparisons are shown. b Relative gene expression in 0.5MM vs. 1MM cardiopatches; *p < 0.041, **p < 0.0073, ***p < 0.0001, post hoc Tukey’s tests. c Protein/DNA ratio in 0.5MM vs. 1MM cardiopatches; n = 3/4 patches (1/0.5MM). d Representative western blots for myosin heavy chain-β (βMHC), SAA, lamin B1 (LamB1), GAPDH, and Cx43 in d0 cells and 3-week 0.5MM and 1MM cardiopatches; dotted line indicates lanes spliced from the same gel. e Quantified protein levels in d0 cells, 1MM and 0.5MM cardiopatches normalized to nuclear envelope protein LamB1, shown relative to 1MM cardiopatches; **p < 0.01, ***p < 0.001 vs. d0; † p < 0.05, †† p < 0.01, ††† p < 0.001 vs. 1MM, post hoc Tukey’s tests. For gene expression studies (a, b), n = 6 patches from two differentiations; for protein studies (c–e), n = 8/10 patches (1/0.5MM) from three to four differentiations. f Representative low-magnification view of cell nucleus (nuc) and surrounding sacromeric structures (sarc) in 3-week-old 0.5MM cardiopatches. Scale bar 2 µm. g Localization of I-bands, Z-discs, and H-zones within hiPSC-CM sarcomeres. Scale bar 1 µm. h Average number of H-zones and I-bands per sarcomere; n = 4 patches from two differentiations, data compiled from a total of 74 random fields of view. i Mitochondria (mito) were found positioned alongside CM myofibrils. Scale bar 500 nm. j, k Evidence of M-bands (j) and T-tubular-like structures (T-t, k) in 3-week-old 0.5MM cardiopatches. Scale bars 500 nm. All data are presented as mean ± SEMCC BY · PubMed Central
Fig. 5 Scale-up of cardiopatches without loss of function. a Representative images of control (ctrl, 7 × 7 mm), Mega (15 × 15 mm) and Giga (36 × 36 mm) cardiopatches at 3 weeks of culture. Scale bar 1 cm. b, c Representative confocal images of 3-week-old Giga cardiopatches stained for Cx43 and SAA, as seen in confocal cross-sections (b) or in the XY plane in the middle of the patch (c). Scale bars 20 µm (b), 10 µm (c). d Representative activation maps of ctrl, Mega, and Giga cardiopatches following point stimulation from bottom right corner (pulse sign). Giga patches were imaged by an EMCCD camera. Scale bar 1 cm. e Conduction velocity (CV) in 3-week-old ctrl, Mega and Giga cardiopatches; n = 11/6/7 patches (ctrl/Mega/Giga) from three to four differentiations; p = 0.56, one-way ANOVA. f Action potential duration at 80% repolarization (APD80) in 3-week-old ctrl, Mega and Giga cardiopatches; n = 11/6/5 patches (ctrl/Mega/Giga) from three to four differentiations; p = 0.52, one-way ANOVA. g Representative isometric force trace from spontaneously contracting 3-week-old Giga cardiopatch at 16% stretch. h, i Maximum active forces (h) and specific forces (i) in 3-week-old ctrl, Mega, and Giga cardiopatches shown relative to Ctrl cardiopatch; n = 10/6/10 patches (ctrl/Mega/Giga) from three to four differentiations; *p < 0.0001 vs. ctrl, # p < 0.01 vs. Mega, post hoc Tukey’s tests; (i) p = 0.76, one-way ANOVA. Data are presented as mean ± SEM
Fig. 5 Scale-up of cardiopatches without loss of function. a Representative images of control (ctrl, 7 × 7 mm), Mega (15 × 15 mm) and Giga (36 × 36 mm) cardiopatches at 3 weeks of culture. Scale bar 1 cm. b, c Representative confocal images of 3-week-old Giga cardiopatches stained for Cx43 and SAA, as seen in confocal cross-sections (b) or in the XY plane in the middle of the patch (c). Scale bars 20 µm (b), 10 µm (c). d Representative activation maps of ctrl, Mega, and Giga cardiopatches following point stimulation from bottom right corner (pulse sign). Giga patches were imaged by an EMCCD camera. Scale bar 1 cm. e Conduction velocity (CV) in 3-week-old ctrl, Mega and Giga cardiopatches; n = 11/6/7 patches (ctrl/Mega/Giga) from three to four differentiations; p = 0.56, one-way ANOVA. f Action potential duration at 80% repolarization (APD80) in 3-week-old ctrl, Mega and Giga cardiopatches; n = 11/6/5 patches (ctrl/Mega/Giga) from three to four differentiations; p = 0.52, one-way ANOVA. g Representative isometric force trace from spontaneously contracting 3-week-old Giga cardiopatch at 16% stretch. h, i Maximum active forces (h) and specific forces (i) in 3-week-old ctrl, Mega, and Giga cardiopatches shown relative to Ctrl cardiopatch; n = 10/6/10 patches (ctrl/Mega/Giga) from three to four differentiations; *p < 0.0001 vs. ctrl, # p < 0.01 vs. Mega, post hoc Tukey’s tests; (i) p = 0.76, one-way ANOVA. Data are presented as mean ± SEMCC BY · PubMed Central
Fig. 6 In vivo vascularization of cardiopatches. a Representative photograph of an implanted 3-week-old cardiopatch (arrow) in a dorsal skinfold window chamber of a nude mouse. b, c Intravital raw vascularization images (b) and quantification of blood vessel density (BVD, c) of cardiopatches on d7 and d14 post implantation relative to blank (Cerex® frame-only) controls; n = 18 mice (15 cardiopatches from 3 differentiations, 3 blank controls); repeated measures ANOVA: time F-ratio 34.8 (p < 0.0001), patch×time interaction effect F-ratio 6.81 (p < 0.02); for cardiopatch at d14: **p < 0.0001 vs. cardiopatch at d7, # p < 0.027 vs. blank at d14, post hoc Tukey’s tests. d, e Representative cross-sections of explanted cardiopatches after 2 weeks in vivo stained for F-actin, cTnT (d, arrow showing the cardiopatch) and CD31 (e, arrow showing a capillary lumen). f Representative en face image of cardiopatch explanted 2 weeks post implantation stained for F-actin and CD31 (arrows pointing to vessel lumens), and SAA and Cx43 (inset). g Representative fluorescence images and time trace of gCaMP6 signal during cardiopatch spontaneous activity 1 week after implantation; f, cardiopatch frame. h Ca2+ transient amplitude assessed as relative gCaMP6 fluorescence (dF/F) in cardiopatches at d7 and d14 following implantation; n = 12 patches from two differentiations; p = 0.2, paired t-test. Data are presented as mean ± SEM. Scale bars a 5 mm; b 1 mm; d 100 µm; e 30 µm; f 20 µm (inset 10 µm); g 1 mm
Fig. 6 In vivo vascularization of cardiopatches. a Representative photograph of an implanted 3-week-old cardiopatch (arrow) in a dorsal skinfold window chamber of a nude mouse. b, c Intravital raw vascularization images (b) and quantification of blood vessel density (BVD, c) of cardiopatches on d7 and d14 post implantation relative to blank (Cerex® frame-only) controls; n = 18 mice (15 cardiopatches from 3 differentiations, 3 blank controls); repeated measures ANOVA: time F-ratio 34.8 (p < 0.0001), patch×time interaction effect F-ratio 6.81 (p < 0.02); for cardiopatch at d14: **p < 0.0001 vs. cardiopatch at d7, # p < 0.027 vs. blank at d14, post hoc Tukey’s tests. d, e Representative cross-sections of explanted cardiopatches after 2 weeks in vivo stained for F-actin, cTnT (d, arrow showing the cardiopatch) and CD31 (e, arrow showing a capillary lumen). f Representative en face image of cardiopatch explanted 2 weeks post implantation stained for F-actin and CD31 (arrows pointing to vessel lumens), and SAA and Cx43 (inset). g Representative fluorescence images and time trace of gCaMP6 signal during cardiopatch spontaneous activity 1 week after implantation; f, cardiopatch frame. h Ca2+ transient amplitude assessed as relative gCaMP6 fluorescence (dF/F) in cardiopatches at d7 and d14 following implantation; n = 12 patches from two differentiations; p = 0.2, paired t-test. Data are presented as mean ± SEM. Scale bars a 5 mm; b 1 mm; d 100 µm; e 30 µm; f 20 µm (inset 10 µm); g 1 mmCC BY · PubMed Central
Fig. 7 Epicardial implantation and ex vivo assessment of cardiopatches. a Representative image of cardiopatch 3 weeks following implantation onto nude rat epicardium; f, cardiopatch frame. b MHCK7-gCaMP6 flashes in implanted cardiopatches following direct stimulation by a platinum electrode; f, cardiopatch frame. c Schematic of a setup for dual optical mapping of gCaMP6-reported Ca2+ transients in implanted cardiopatches and Di-4-ANEPPS-reported transmembrane voltage in Langendorff-perfused rat hearts. d Representative snapshots from movies of Ca2+ transients in cardiopatches (green) and membrane voltage in the heart (red). Traces at the bottom show representative gCaMP6 (green) and Di-4 (red) signals from a single recording channel with yellow line denoting point in time corresponding to the instant of the movie snapshot. Pulse sign denotes location of stimulus electrode;p, paced; s, spontaneous. e Representative isochronal maps of action potential propagation during direct point electrode stimulation (pulse sign) of implanted cardiopatch (black dashed outline) and underlying rat myocardium (red dashed outline). f CV and APD of host epicardium optically recorded in control conditions (no patch), under implanted cardiopatch (under patch), and remote from implanted cardiopatch (away from patch); n = 6/3/3 (control/under/away). g, h Representative cross-sections of cardiopatch 3 weeks after implantation onto rat epicardium stained for SAA, von Willebrand Factor (vWF), and human nuclear antigen (HNA, h) and SAA and Cx43 (h). Data are presented as mean ± SEM. Scale bars a 1 cm; B1–2 2 mm; d, e 2 mm; g main: 250 µm, left inset: 100 µm, right inset: 25 µm; h 50 µm
Fig. 7 Epicardial implantation and ex vivo assessment of cardiopatches. a Representative image of cardiopatch 3 weeks following implantation onto nude rat epicardium; f, cardiopatch frame. b MHCK7-gCaMP6 flashes in implanted cardiopatches following direct stimulation by a platinum electrode; f, cardiopatch frame. c Schematic of a setup for dual optical mapping of gCaMP6-reported Ca2+ transients in implanted cardiopatches and Di-4-ANEPPS-reported transmembrane voltage in Langendorff-perfused rat hearts. d Representative snapshots from movies of Ca2+ transients in cardiopatches (green) and membrane voltage in the heart (red). Traces at the bottom show representative gCaMP6 (green) and Di-4 (red) signals from a single recording channel with yellow line denoting point in time corresponding to the instant of the movie snapshot. Pulse sign denotes location of stimulus electrode;p, paced; s, spontaneous. e Representative isochronal maps of action potential propagation during direct point electrode stimulation (pulse sign) of implanted cardiopatch (black dashed outline) and underlying rat myocardium (red dashed outline). f CV and APD of host epicardium optically recorded in control conditions (no patch), under implanted cardiopatch (under patch), and remote from implanted cardiopatch (away from patch); n = 6/3/3 (control/under/away). g, h Representative cross-sections of cardiopatch 3 weeks after implantation onto rat epicardium stained for SAA, von Willebrand Factor (vWF), and human nuclear antigen (HNA, h) and SAA and Cx43 (h). Data are presented as mean ± SEM. Scale bars a 1 cm; B1–2 2 mm; d, e 2 mm; g main: 250 µm, left inset: 100 µm, right inset: 25 µm; h 50 µmCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 69 references

Research works printed but not linked: 1

  1. Weinberger, F. et al. Cardiac repair in guinea pigs with human engineered heart tissue from induced pluripotent stem cells. Sci. Transl. Med. 8, 363ra148 (2016). · DOI · Paper page

Cited by

See all 426

Metadata

Authors
Shadrin, I. Y., Allen, B. W., Qian, Y., Jackman, C. P., Carlson, A. L., Juhas, M. E., & Bursac, N.
Affiliations
Duke University (US)
Corresponding author
Bursac, Nenad
Venue
Nature Communications
Published
2017-11-28
Volume
8
Issue
1
Pages
1825-1825
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2768142457
Cited by
420
References
69
Citations by year
2026: 16 · 2025: 38 · 2024: 40 · 2023: 55 · 2022: 52 · 2021: 67 · 2020: 59 · 2019: 61 · 2018: 32
FWCI
16.99
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Institutes of Health (UG3TR002142, 5r01hl104326-05)
  • National Heart, Lung, and Blood Institute (R01HL132389, R01-HL104326, F30HL122079, U01HL134764, R01HL126524)
  • National Institute of General Medical Sciences (T32GM007171)
  • National Center for Advancing Translational Sciences
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
Keywords
human induced pluripotent stem cell-derived cardiomyocytes, engineered heart tissue, cardiomyocyte maturation, scale-up, electromechanical coupling, T-tubules, M-band, conduction velocity, vascularization, cardiac arrhythmias, cardiac repair, cell therapy
MeSH terms
Animals, Arrhythmias, Cardiac, Calcium, Cell Differentiation, Cell Line, Cells, Cultured, Disease Models, Animal, Humans, Male, Mice, Nude, Myocardial Contraction, Myocardial Infarction, Myocardium, Sarcomeres, Tissue Engineering, Myocytes, Cardiac, Pluripotent Stem Cells, Mice, Rats, Induced Pluripotent Stem Cells, Heterografts

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cardiopatch platform enables maturation and scale-up of human pluripotent stem cell-derived engineered heart tissues. https://app.cochat.ai/papers/10.1038/s41467-017-01946-x
The paper
Shadrin, I. Y., Allen, B. W., Qian, Y., Jackman, C. P., Carlson, A. L., Juhas, M. E., & Bursac, N. (2017). Cardiopatch platform enables maturation and scale-up of human pluripotent stem cell-derived engineered heart tissues. Nature Communications. https://doi.org/10.1038/s41467-017-01946-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.